UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial

Mayo Clinic proceedings, 2005-05, Vol.80 (5), p.587-595

2005

Volltextzugriff (PDF)

Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study

Clinical therapeutics, 2002-11, Vol.24 (11), p.1871-1886

2002

Volltextzugriff (PDF)

Effectiveness of Ezetimibe Added to Ongoing Statin Therapy in Modifying Lipid Profiles and Low-Density Lipoprotein Cholesterol Goal Attainment in Patients of Different Races and Ethnicities: A Substudy of the Ezetimibe Add-On to Statin for Effectiveness Trial

Mayo Clinic proceedings, 2006-09, Vol.81 (9), p.1177-1185

2006

Volltextzugriff (PDF)

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Menopause (New York, N.Y.), 2004-07, Vol.11 (4), p.405-415

2004

Volltextzugriff (PDF)

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study

The American heart journal, 2005-03, Vol.149 (3), p.464-473

2005

Volltextzugriff (PDF)

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

JAMA : the journal of the American Medical Association, 2004-09, Vol.292 (11), p.1307

2004

Volltextzugriff (PDF)

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

The American journal of cardiology, 2005-02, Vol.95 (4), p.462-468

2005

Volltextzugriff (PDF)

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms

Clinical therapeutics, 2000-12, Vol.22 (12), p.1433-1442

2000

Volltextzugriff (PDF)

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia

The American journal of cardiology, 2004-06, Vol.93 (12), p.1487-1494

2004

Volltextzugriff (PDF)

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: Subanalyses of data from a randomized, double-blind, placebo-controlled trial

The American journal of geriatric pharmacotherapy, 2005-12, Vol.3 (4), p.218-228

2005

Volltextzugriff (PDF)

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2004-07, Vol.292 (1), p.55

2004

Volltextzugriff (PDF)

Developing Drugs for Rare Diseases: Regulatory Strategies and Considerations

Drug Development for Rare Diseases, 2023, p.17-33

1, 2023

Volltextzugriff (PDF)

Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment

Genomics (San Diego, Calif.), 2005-12, Vol.86 (6), p.648-656

2005

Volltextzugriff (PDF)

Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials

Current medical research and opinion, 2005-07, Vol.21 (7), p.1123-1130

2005

Volltextzugriff (PDF)

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

The American journal of gastroenterology, 2000-09, Vol.95 (9), p.2457-2457

2000

Volltextzugriff (PDF)

Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study

Mayo Clinic proceedings, 2002-10, Vol.77 (10), p.1044-1052

2002

Volltextzugriff (PDF)

Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: Results of the Comparative HDL Efficacy and Safety Study (CHESS)

The American heart journal, 2003-11, Vol.146 (5), p.862-869

2003

Volltextzugriff (PDF)

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial

European heart journal, 2004-10, Vol.25 (19), p.1688-1694

2004

Volltextzugriff (PDF)

Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease

Clinical chemistry and laboratory medicine, 2003-09, Vol.41 (9), p.1174-1181

2003

Volltextzugriff (PDF)

Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss

EJD. European journal of dermatology, 2003-03, Vol.13 (2), p.150-160

2003

Volltextzugriff (PDF)

Ezetimibe/Simvastatin Versus Atorvastatin for Patients Who Have Diabetes Mellitus and Hypercholesterolemia

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A235

2005

Volltextzugriff (PDF)

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d

Clinical therapeutics, 2003-11, Vol.25 (11), p.2738-2753

2003

Volltextzugriff (PDF)

1084-176 Efficacy of ezetimibe coadministered with simvastatin versus atorvastatin in patients with hypercholesterolemia

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A480-A481

2004

Volltextzugriff (PDF)

Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C

Current medical research and opinion, 2004-07, Vol.20 (7), p.1087-1094

2004

Volltextzugriff (PDF)

Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data

Diabetes care, 1998-12, Vol.21 (12), p.2129-2134

1998

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(27)

Publikationsform

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

Humans
(27)
Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Biological And Medical Sciences
(19)
Female
(19)
Male
(18)
Medical Sciences
(18)
Middle Aged
(18)
Double-Blind Method
(13)
Aged
(11)
Adult
(9)
Drug Therapy, Combination
(9)
Treatment Outcome
(9)
Ezetimibe
(8)
General & Internal Medicine
(8)
Medicine, General & Internal
(8)
Cardiology. Vascular System
(7)
Hypercholesterolemia - Drug Therapy
(7)
Cholesterol, Ldl - Blood
(6)
Hydroxymethylglutaryl-Coa Reductase Inhibitors - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial

Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study

Effectiveness of Ezetimibe Added to Ongoing Statin Therapy in Modifying Lipid Profiles and Low-Density Lipoprotein Cholesterol Goal Attainment in Patients of Different Races and Ethnicities: A Substudy of the Ezetimibe Add-On to Statin for Effectiveness Trial

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: Subanalyses of data from a randomized, double-blind, placebo-controlled trial

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

Developing Drugs for Rare Diseases: Regulatory Strategies and Considerations

Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment

Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study

Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: Results of the Comparative HDL Efficacy and Safety Study (CHESS)

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial

Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease

Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss

Ezetimibe/Simvastatin Versus Atorvastatin for Patients Who Have Diabetes Mellitus and Hypercholesterolemia

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d

1084-176 Efficacy of ezetimibe coadministered with simvastatin versus atorvastatin in patients with hypercholesterolemia

Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C

Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data

Aktive Filter

Suchergebnisse filtern